Koers Neurokine Pharmaceuticals Inc Other OTC
Aandelen
CAC611561100
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 13,32 mln. 12,48 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -12 mln. -11,25 mln. | Nettowinst (verlies) 2023 | -9 mln. -8,43 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 139K 130K | Nettoschuld 2023 | 71,69K 67,19K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,26
x | K/w-verhouding 2023 |
-1,36
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 77,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26-12-10 |
Chief Operating Officer | 67 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05-02-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,46% | 102 mld. | |
+1,41% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,84% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,65% | 16,36 mld. | |
+4,39% | 13,97 mld. | |
+31,35% | 12,17 mld. |
- Beurs
- Aandelen
- Koers BETRF
- Koers